|
CN112174834A
|
|
Eptacrine hydrochloride B crystal form and preparation method thereof
|
|
CN112174833A
|
|
Crystal form A of escargoline hydrochloride and preparation method thereof
|
|
CN112137976A
|
|
Aripiprazole sustained-release tablet and preparation method thereof
|
|
CN112028887A
|
|
Penehyclidine hydrochloride impurity and preparation method thereof
|
|
CN111925281A
|
|
Preparation method of penehyclidine hydrochloride impurity 2-cyclopentyl-2-phenylacetaldehyde
|
|
CN111410658A
|
|
Impurity A and impurity B of midazolam or pharmaceutical composition thereof and application thereof
|
|
CN111377911A
|
|
Morpholine benzamide compound and application thereof
|
|
CN111377846A
|
|
Piperazine benzamide derivative and application thereof
|
|
CN111320582A
|
|
Preparation method of amide-like derivative and intermediate thereof
|
|
CN111320619A
|
|
Impurities of amide-like derivatives and application
|
|
CN111320632A
|
|
Novel crystal form of midazolam hydrochloride and preparation method thereof
|
|
CN111320593A
|
|
Refining method of high-purity Carilazine
|
|
CN111320594A
|
|
Carilazine impurity and preparation process and application thereof
|
|
CN111285819A
|
|
Benzoxazole compound and application thereof
|
|
CN111285843A
|
|
Novel 5-hydroxytryptamine and norepinephrine dual reuptake inhibitor and medical application thereof
|
|
CN111285862A
|
|
Crystal form of propionamide derivative and preparation method thereof
|
|
CN110407867A
|
|
The novel crystal forms and preparation method thereof of valproic acid phospholipid derivative
|
|
CN109280037A
|
|
3- cyano benzene oxyalkyl aryl piperazine derivative and application in medicine preparation
|
|
CN109280030A
|
|
Benzene a pair of horses going side by side azepine alkylaryl bridged piperazine derivatives and application in medicine preparation
|
|
AU2017300185A1
|
|
Extended release dosage forms of pregabalin
|
